Literature DB >> 31601998

LIN28B increases neural crest cell migration and leads to transformation of trunk sympathoadrenal precursors.

Diana Corallo1, Michael Donadon2, Marcella Pantile2, Viktoryia Sidarovich3, Simona Cocchi3, Michela Ori4, Miriam De Sarlo4, Simona Candiani5, Chiara Frasson6, Martin Distel7, Alessandro Quattrone3, Carlo Zanon6, Giuseppe Basso8, Gian Paolo Tonini2, Sanja Aveic9,10.   

Abstract

The RNA-binding protein LIN28B regulates developmental timing and determines stem cell identity by suppressing the let-7 family of microRNAs. Postembryonic reactivation of LIN28B impairs cell commitment to differentiation, prompting their transformation. In this study, we assessed the extent to which ectopic lin28b expression modulates the physiological behavior of neural crest cells (NCC) and governs their transformation in the trunk region of developing embryos. We provide evidence that the overexpression of lin28b inhibits sympathoadrenal cell differentiation and accelerates NCC migration in two vertebrate models, Xenopus leavis and Danio rerio. Our results highlight the relevance of ITGA5 and ITGA6 in the LIN28B-dependent regulation of the invasive motility of tumor cells. The results also establish that LIN28B overexpression supports neuroblastoma onset and the metastatic potential of malignant cells through let-7a-dependent and let-7a-independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31601998      PMCID: PMC7206034          DOI: 10.1038/s41418-019-0425-3

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  49 in total

Review 1.  Neuroblastoma (Peripheral neuroblastic tumours).

Authors:  Roberto Luksch; Maria Rita Castellani; Paola Collini; Bruno De Bernardi; Massimo Conte; Claudio Gambini; Lorenza Gandola; Alberto Garaventa; Davide Biasoni; Marta Podda; Angela Rita Sementa; Gemma Gatta; Gian Paolo Tonini
Journal:  Crit Rev Oncol Hematol       Date:  2016-10-06       Impact factor: 6.312

2.  The International Neuroblastoma Pathology Classification (the Shimada system).

Authors:  H Shimada; I M Ambros; L P Dehner; J Hata; V V Joshi; B Roald; D O Stram; R B Gerbing; J N Lukens; K K Matthay; R P Castleberry
Journal:  Cancer       Date:  1999-07-15       Impact factor: 6.860

3.  The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.

Authors:  Susan L Cohn; Andrew D J Pearson; Wendy B London; Tom Monclair; Peter F Ambros; Garrett M Brodeur; Andreas Faldum; Barbara Hero; Tomoko Iehara; David Machin; Veronique Mosseri; Thorsten Simon; Alberto Garaventa; Victoria Castel; Katherine K Matthay
Journal:  J Clin Oncol       Date:  2008-12-01       Impact factor: 44.544

4.  LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.

Authors:  Jan J Molenaar; Raquel Domingo-Fernández; Marli E Ebus; Sven Lindner; Jan Koster; Ksenija Drabek; Pieter Mestdagh; Peter van Sluis; Linda J Valentijn; Johan van Nes; Marloes Broekmans; Franciska Haneveld; Richard Volckmann; Isabella Bray; Lukas Heukamp; Annika Sprüssel; Theresa Thor; Kristina Kieckbusch; Ludger Klein-Hitpass; Matthias Fischer; Jo Vandesompele; Alexander Schramm; Max M van Noesel; Luigi Varesio; Frank Speleman; Angelika Eggert; Raymond L Stallings; Huib N Caron; Rogier Versteeg; Johannes H Schulte
Journal:  Nat Genet       Date:  2012-10-07       Impact factor: 38.330

5.  Antibody markers identify a common progenitor to sympathetic neurons and chromaffin cells in vivo and reveal the timing of commitment to neuronal differentiation in the sympathoadrenal lineage.

Authors:  D J Anderson; J F Carnahan; A Michelsohn; P H Patterson
Journal:  J Neurosci       Date:  1991-11       Impact factor: 6.167

6.  LIN28B fosters colon cancer migration, invasion and transformation through let-7-dependent and -independent mechanisms.

Authors:  C E King; L Wang; R Winograd; B B Madison; P S Mongroo; C N Johnstone; A K Rustgi
Journal:  Oncogene       Date:  2011-05-30       Impact factor: 9.867

7.  High expression of Lin28 is associated with tumour aggressiveness and poor prognosis of patients in oesophagus cancer.

Authors:  R Hamano; H Miyata; M Yamasaki; K Sugimura; K Tanaka; Y Kurokawa; K Nakajima; S Takiguchi; Y Fujiwara; M Mori; Y Doki
Journal:  Br J Cancer       Date:  2012-03-20       Impact factor: 7.640

8.  Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes.

Authors:  Katleen De Preter; Jo Vandesompele; Pierre Heimann; Nurten Yigit; Siv Beckman; Alexander Schramm; Angelika Eggert; Raymond L Stallings; Yves Benoit; Marleen Renard; Anne De Paepe; Geneviève Laureys; Sven Påhlman; Frank Speleman
Journal:  Genome Biol       Date:  2006       Impact factor: 13.583

Review 9.  Oncogenic mechanisms of Lin28 in breast cancer: new functions and therapeutic opportunities.

Authors:  Hanchu Xiong; Wenhe Zhao; Ji Wang; Benjamin J Seifer; Chenyang Ye; Yongxia Chen; Yunlu Jia; Cong Chen; Jianguo Shen; Linbo Wang; Xinbing Sui; Jichun Zhou
Journal:  Oncotarget       Date:  2017-04-11

10.  The genetic landscape of high-risk neuroblastoma.

Authors:  Trevor J Pugh; Olena Morozova; Edward F Attiyeh; Shahab Asgharzadeh; Jun S Wei; Daniel Auclair; Scott L Carter; Kristian Cibulskis; Megan Hanna; Adam Kiezun; Jaegil Kim; Michael S Lawrence; Lee Lichenstein; Aaron McKenna; Chandra Sekhar Pedamallu; Alex H Ramos; Erica Shefler; Andrey Sivachenko; Carrie Sougnez; Chip Stewart; Adrian Ally; Inanc Birol; Readman Chiu; Richard D Corbett; Martin Hirst; Shaun D Jackman; Baljit Kamoh; Alireza Hadj Khodabakshi; Martin Krzywinski; Allan Lo; Richard A Moore; Karen L Mungall; Jenny Qian; Angela Tam; Nina Thiessen; Yongjun Zhao; Kristina A Cole; Maura Diamond; Sharon J Diskin; Yael P Mosse; Andrew C Wood; Lingyun Ji; Richard Sposto; Thomas Badgett; Wendy B London; Yvonne Moyer; Julie M Gastier-Foster; Malcolm A Smith; Jaime M Guidry Auvil; Daniela S Gerhard; Michael D Hogarty; Steven J M Jones; Eric S Lander; Stacey B Gabriel; Gad Getz; Robert C Seeger; Javed Khan; Marco A Marra; Matthew Meyerson; John M Maris
Journal:  Nat Genet       Date:  2013-01-20       Impact factor: 38.330

View more
  6 in total

1.  Identification of RNA-Binding Proteins as Targetable Putative Oncogenes in Neuroblastoma.

Authors:  Jessica L Bell; Sven Hagemann; Jessica K Holien; Tao Liu; Zsuzsanna Nagy; Johannes H Schulte; Danny Misiak; Stefan Hüttelmaier
Journal:  Int J Mol Sci       Date:  2020-07-19       Impact factor: 5.923

2.  LIN28B regulates transcription and potentiates MYCN-induced neuroblastoma through binding to ZNF143 at target gene promotors.

Authors:  Ting Tao; Hui Shi; Luca Mariani; Brian J Abraham; Adam D Durbin; Mark W Zimmerman; John T Powers; Pavlos Missios; Kenneth N Ross; Antonio R Perez-Atayde; Martha L Bulyk; Richard A Young; George Q Daley; A Thomas Look
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-29       Impact factor: 11.205

Review 3.  An Overview of Long Non-Coding (lnc)RNAs in Neuroblastoma.

Authors:  Francesca Baldini; Matilde Calderoni; Laura Vergani; Paola Modesto; Tullio Florio; Aldo Pagano
Journal:  Int J Mol Sci       Date:  2021-04-19       Impact factor: 5.923

4.  MicroRNA-147a Targets SLC40A1 to Induce Ferroptosis in Human Glioblastoma.

Authors:  Peng Xu; Fei-Hang Ge; Wen-Xin Li; Zhen Xu; Xue-Li Wang; Jing-Lan Shen; Ai-Bo Xu; Rong-Rong Hao
Journal:  Anal Cell Pathol (Amst)       Date:  2022-07-30       Impact factor: 4.133

5.  MicroRNA-1224-5p Aggravates Sepsis-Related Acute Lung Injury in Mice.

Authors:  Bing Liu; Feng Chen; Ni-Tao Cheng; Zheng Tang; Xian-Guo Wang; Ming Xu
Journal:  Oxid Med Cell Longev       Date:  2022-06-28       Impact factor: 7.310

Review 6.  Molecular Genetics in Neuroblastoma Prognosis.

Authors:  Margherita Lerone; Marzia Ognibene; Annalisa Pezzolo; Giuseppe Martucciello; Federico Zara; Martina Morini; Katia Mazzocco
Journal:  Children (Basel)       Date:  2021-05-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.